What Is the GLOW Peptide? GHK-Cu + BPC-157 + TB-500 Blend Overview

Total peptide content is 70 mg per vial as supplied; the per-component specification is listed on the product page. The three molecules span an order of magnitude in size and include a metal complex — which shapes what proper analytical documentation for this blend has to demonstrate.

The distinguishing component of GLOW relative to the Wolverine pairing is GHK-Cu: the plasma-derived tripeptide Gly-His-Lys coordinated to a copper(II) ion. Its published in vitro biology is dominated by extracellular-matrix themes — stimulation of collagen and glycosaminoglycan synthesis in fibroblast culture, bidirectional regulation of matrix metalloproteinases and their tissue inhibitors, and intracellular copper delivery, copper being the catalytic metal of lysyl oxidase, the enzyme that cross-links collagen and elastin (Pickart L, Margolina A. Int J Mol Sci. 2018;19(7):1987). Broad gene-profiling studies have mapped fibroblast transcriptional responses to the complex across hundreds of genes, which is why GHK-Cu appears throughout the dermal-model research literature. The full single-compound treatment is at GHK-Cu.

A chemistry point specific to blending: GHK-Cu is a metal-coordination complex, not a plain peptide. In a mixed preparation, its copper center is part of its identity — analytical characterization of the blend has to treat it as such rather than as one more sequence to confirm.

BPC-157 is a 15-residue peptide (~1,419 Da) whose sequence derives from a protective gastric-juice protein, notable for unusual aqueous stability and for one of the largest bodies of model-organism literature in the research-peptide space. Published mechanistic threads include modulation of nitric-oxide pathways, effects on growth-factor-receptor expression — VEGFR2 in endothelial assays most prominently — and cytoprotective outcomes across a long list of chemically induced injury models in animal-model work (Sikiric P, et al. Curr Pharm Des. 2018;24(18):1990–2001; Hsieh MJ, et al. J Mol Med (Berl). 2017;95(3):323–333). Within the blend, it is the component whose literature is most about signaling-level modulation of the cell types the other two components also touch. Full overview: BPC-157.

TB-500 is the research-market name attached to the thymosin β4 literature. Thymosin β4 is a 43-residue actin-binding peptide whose characterized cellular role is sequestering monomeric G-actin, placing it at the center of actin polymerization — the physical machinery of cell movement — with an internal binding motif (LKKTETQ) that has been synthesized and studied as an active fragment in its own right (Goldstein AL, et al. Ann N Y Acad Sci. 2010;1194:118–124). As covered in the Wolverine blend overview, the market name is applied inconsistently across the industry to both the full-length peptide and the fragment; the two differ substantially in mass, and mass-spectrometry identity testing is what settles which a given lot contains. Full overview: TB-500.

The three literatures partition the biology of remodeling tissue cleanly: GHK-Cu's published work addresses the matrix — the scaffold and the enzymes that build and cut it; the thymosin β4 axis addresses movement — the actin mechanics by which cells traverse that scaffold; and BPC-157's addresses signaling — the pathway-level modulation of the same fibroblast and endothelial populations. An in vitro program working in dermal or matrix-remodeling models can use the fixed-ratio trio to probe all three arms in one preparation, which is the practical reason this particular combination hardened into a named market formulation. Researchers wanting the inflammation arm as well typically look to the four-component KLOW blend, which adds KPV to this exact base.

• Three identities, one of them a metal complex. Identity confirmation spans a ~402 Da copper complex, a ~1,419 Da pentadecapeptide, and the TB-500 component — with the copper coordination itself part of what must be characterized.
• Peak assignment across a wide mass range. Purity for a blend is read per-component from assigned peak families, not as a single main-peak percentage.
• Ratio verification. The fixed ratio is the point of a blend; chromatographic peak areas per lot are the check on it.
• The TB-500 identity question. Full-length versus fragment is a lot-level fact only mass spectrometry answers.

HEEZ Research supplies GLOW as a lyophilized preparation with independent third-party HPLC and mass-spectrometry testing; Certificates of Analysis are published on product pages as testing is completed — review the report before you order. Current specifications are on the GLOW product page.